A Simplified Therapy Regimen Study of Lopinavir and Ritonavir Combined With Lamivudine for HIV-1 Infected Patients in the Real World of China
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• HIV-1 infection confirmed
• Agree to use simplified therapy regimen.
• Agree to detect CD4 count at least once per half a year
Locations
Other Locations
China
Guangzhou 8th People's Hospital
RECRUITING
Guangzhou
Contact Information
Primary
Linghua Li, Doctor
llheliza@126.com
020-83710825
Backup
Weiping Cai, Bachelor
gz8hcwp@126.com
020-83710816
Time Frame
Start Date: 2017-11-01
Estimated Completion Date: 2030-10-31
Participants
Target number of participants: 600
Treatments
Lpv/r+3TC
These cases were given simplified therapy regimen including lopinavir(200mg) and ritonavir(50mg)500 mg,oral,bid) combined with lamivudine (300 mg,oral,qd).
Related Therapeutic Areas
Sponsors
Collaborators: The Second People's Hospital of Nanjing, Guangxi Longtan hospital, The Sixth People's Hospital of Shenyang, LiuZhou People's Hospital, The Fourth People's Hospital of Nanning, The Sixth People's Hospital of Xinjiang, Tianjin Second People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The Eighth People's Hospital of Xi'an, Guiyang Public Health Clinical Center, The Sixth People's Hospital of Henan, The Third People's Hospital of Kunming, The Third People's Hospital of Guilin
Leads: Guangzhou 8th People's Hospital